Sun Pharma Inds. - Quaterly Results
Date: 31-01-2025
The Revenue for the quarter ended December 2024 of Rs. 61918.10 millions grew by 22.04 % from Rs. 50737.50 millions.Handsome Net Profit growth of 63.74% reported above the corresponding previous quarter figure of Rs. 11810.50 millions to Rs. 7213.10 millions.Operating profit for the quarter ended December 2024 rose to 17718.60 millions as compared to 14358.00 millions of corresponding quarter ended December 2023.
| | Quarter ended | Year to Date | Year ended |
| | 202412 | 202312 | % Var | 202412 | 202312 | % Var | 202403 | 202303 | % Var |
| Sales | 61918.10 | 50737.50 | 22.04 | 158175.90 | 146360.30 | 8.07 | 202751.70 | 208121.40 | -2.58 |
| Other Income | 683.90 | 2284.80 | -70.07 | 3657.60 | 5079.50 | -27.99 | 5534.80 | 3292.90 | 68.08 |
| PBIDT | 17718.60 | 14358.00 | 23.41 | 40405.90 | 40409.60 | -0.01 | 60533.70 | 67518.90 | -10.35 |
| Interest | 2159.60 | 2149.20 | 0.48 | 6757.90 | 5664.90 | 19.29 | 7840.80 | 4721.80 | 66.06 |
| PBDT | 15559.00 | 11510.70 | 35.17 | 33648.00 | 32554.50 | 3.36 | 50502.70 | 33419.20 | 51.12 |
| Depreciation | 2909.70 | 3996.00 | -27.18 | 9463.10 | 12075.80 | -21.64 | 16006.20 | 16008.70 | -0.02 |
| PBT | 12649.30 | 7514.70 | 68.33 | 24184.90 | 20478.70 | 18.10 | 34496.50 | 17410.50 | 98.14 |
| TAX | 838.80 | 301.60 | 178.12 | 1363.30 | 572.90 | 137.96 | 5914.70 | 503.30 | 1075.18 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 11810.50 | 7213.10 | 63.74 | 22821.60 | 19905.80 | 14.65 | 28581.80 | 16907.20 | 69.05 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 28.62 | 28.30 | 1.12 | 25.54 | 27.61 | -7.48 | 29.86 | 32.44 | -7.97 |